naturalgasbad@lemmy.ca to World News@lemmy.worldEnglish · 2 years agoChina’s new cancer drug Toripalimab is approved in the US but will cost 30 times morewww.scmp.comexternal-linkmessage-square41fedilinkarrow-up187arrow-down115cross-posted to: [email protected]
arrow-up172arrow-down1external-linkChina’s new cancer drug Toripalimab is approved in the US but will cost 30 times morewww.scmp.comnaturalgasbad@lemmy.ca to World News@lemmy.worldEnglish · 2 years agomessage-square41fedilinkcross-posted to: [email protected]
minus-squarenaturalgasbad@lemmy.caOPlinkfedilinkEnglisharrow-up2·2 years agoJunshi owns the IP and is licensing it out to Coherus.
Junshi owns the IP and is licensing it out to Coherus.